ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2024
Impact of stewardship pharmacist driven MRSA nasal surveillance and de-escalation of anti-MRSA therapy (STEW PHARM MRSA NASAL SURVEILLANCE).
Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin: A Randomized Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Trial
- A Quality Improvement Project to Increase Pharmacist-Initiated Methicillin ResistantThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026Article
- Implementation of an automated methicillin-resistantAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine if implementing stewardship pharmacist-driven methicillin-resistant Design: Retrospective pre-/post-intervention study. Setting: Large teaching acute care hospital. Participants: Adult patients receiving vancomycin therapy for treatment of pneumonia. Methods: A stewardship pharmacist ran a report of admitted patients receiving vancomycin and reviewed the patients' records. If the patient's indication was pneumonia and a MRSA nasal swab had not been ordered, the pharmacist contacted the patient's provider and requested an order for it. Upon receipt of a negative MRSA nasal swab result, the pharmacist recommended discontinuation of vancomycin if appropriate.The control group was four weeks prior to the stewardship intervention, where there was no dedicated stewardship pharmacist reviewing MRSA swab utilization. The primary outcome was percentage of patients who had a MRSA swab ordered. Secondary outcomes included percentage of patients who had vancomycin appropriately de-escalated based on MRSA nasal swab results and length of vancomycin therapy. Result: Percentage of swabs ordered increased from 36.1% (22/61) to 83.7% (41/49) with pharmacist intervention ( Conclusion: The results suggest implementing a pharmacist driven MRSA nasal surveillance program into practice could increase the number of MRSA nasal swabs ordered and promote timely de-escalation of vancomycin in patients with pneumonia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.